Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
18-Aug-25 | Sell | Dame Kay Davies | 500.40p | 4,563 | £22,833.25 |
15-Aug-25 | Buy | Roch Doliveux | 449.75p | 67,000 | £301,332.50 |
11-Aug-25 | Buy | Dame Kay Davies | 436.00p | 4,563 | £19,894.68 |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
15-Aug-25 | Buy | Roch Doliveux | 449.75p | 67,000 | £301,332.50 |
18-Aug-25 | Sell | Dame Kay Davies | 500.40p | 4,563 | £22,833.25 |
11-Aug-25 | Buy | Dame Kay Davies | 436.00p | 4,563 | £19,894.68 |
Notifier | Holding | Value* |
---|---|---|
Roch Doliveux | 376,808 | £2,132,733 |
Heather Preston | 29,687 | £168,028 |
Frank Mathias | 20,000 | £113,200 |
Namrata P Patel | 9,170 | £51,902 |
Dame Kay Davies | 1,000 | £5,660 |
Notifier** | Holding | Value* |
---|---|---|
Briarwood Chase Management LLC | 18,638,801 | £105,495,614 |
Briarwood Chase Management LLC | 13,851,927 | £78,401,907 |
Novo Nordisk Foundation | 12,048,802 | £68,196,219 |
Institut Merieux SA | 11,510,481 | £65,149,322 |
VULPES LIFE SCIENCES FUND | 8,447,390 | £47,812,227 |
Liontrust Asset Management | 6,078,799 | £34,406,002 |
M&G Plc | 5,872,847 | £33,240,314 |
Legal & General Group Plc | 5,760,126 | £32,602,313 |
HSBC Global Custody Nominee (UK) Ltd | 4,700,000 | £26,602,000 |
Ameriprise Financial, Inc. | 4,108,146 | £23,252,106 |
Columbia Threadneedle Investments (London) | 3,834,977 | £21,705,970 |
Canaccord Genuity Group Inc | 3,699,438 | £20,938,819 |
Hargreaves Lansdown Asset Management | 3,475,237 | £19,669,841 |
SERUM LIFE SCIENCES LTD | 3,382,950 | £19,147,497 |
Nine Ten Capital | 3,117,228 | £17,643,510 |
Lansdowne Partners (London) | 3,085,765 | £17,465,430 |
Mr. S Shah | 2,898,750 | £16,406,925 |
Artisan Partners | 2,620,800 | £14,833,728 |
Cubana Investments Limited | 2,506,000 | £14,183,960 |
Interactive Investor Sharedealing | 2,372,412 | £13,427,852 |
TDWaterhouse | 852,076 | £4,822,750 |
Self Trade Stockbrokers | 657,039 | £3,718,841 |
Currency | UK Pounds |
Share Price | 566.00p |
Change Today | -5.00p |
% Change | -0.88 % |
52 Week High | 578.00p |
52 Week Low | 232.50p |
Volume | 101,891 |
Shares Issued | 120.17m |
Market Cap | £680.18m |
RiskGrade | 125 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 4 |
Buy | 2 |
Neutral | 4 |
Sell | 0 |
Strong Sell | 0 |
Total | 10 |
No dividends found |
Time | Volume / Share Price |
16:35 | 252 @ 566.00p |
16:35 | 15,574 @ 566.00p |
16:35 | 73 @ 566.00p |
16:35 | 50 @ 566.00p |
16:35 | 46 @ 566.00p |
Chair | Roch Doliveux |
CEO | Frank Mathias |
CFO | Lucinda (Lucy) Crabtree |
You are here: research